BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38236548)

  • 1. Treatment outcomes and risk factors of patients with intracranial germ cell tumour with choriocarcinoma element or β-HCG level higher than 500 IU/L.
    Feng J; Zhang J; Chen L; Li C; Liu W; Chen H; Qiu X; Li B
    J Neurooncol; 2024 Jan; 166(2):331-339. PubMed ID: 38236548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and therapeutic problems of primary intracranial choriocarcinoma/germ-cell tumors with high levels of HCG.
    Shinoda J; Sakai N; Yano H; Hattori T; Ohkuma A; Sakaguchi H
    J Neurooncol; 2004 Jan; 66(1-2):225-40. PubMed ID: 15015791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
    Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
    J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
    Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
    Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
    Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors.
    Hong KT; Han JW; Fuji H; Byun HK; Koh KN; Wong RX; Lee HL; Yoon HI; Lee JH; Phi JH; Kim SK; Kim DS; Lyu CJ; Choi JY; Kang HJ; Chen YW; Lee YY; Im HJ; Ra YS; Do Ahn S; Low SYY; Looi WS; Park HJ; Suh YG; Suh CO; Wang KC; Tan EEK; Wong TT; Kim JY
    J Neurooncol; 2022 Oct; 160(1):41-53. PubMed ID: 36045266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gonadotropin, as a tumor marker, in body fluid and tumor tissues of germ cell tumors].
    Kurisaka M; Saitoh S; Seike M; Kamimura Y; Mori K
    No To Shinkei; 1989 Apr; 41(4):353-9. PubMed ID: 2548547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracranial Germ Cell Tumors in Adolescents and Young Adults: A 40-Year Multi-Institutional Review of Outcomes.
    Lo AC; Hodgson D; Dang J; Tyldesley S; Bouffet E; Bartels U; Cheng S; Hukin J; Bedard PL; Goddard K; Laperriere N
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):269-278. PubMed ID: 31654785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapsing intracranial germ cell tumours warrant retreatment.
    Callec L; Lardy-Cleaud A; Guerrini-Rousseau L; Alapetite C; Vignon L; Chastagner P; Frappaz D; Faure-Conter C
    Eur J Cancer; 2020 Sep; 136():186-194. PubMed ID: 32711377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of immunohistochemistry for neuro-oncology. IV. Distribution model of beta human chorionic gonadotropins in intracranial germ cell tumors].
    Gottschalk J; Martin H; Rohde W; Lehmann J; Schneider J; Kamenova M
    Zentralbl Allg Pathol; 1986; 132(3):215-22. PubMed ID: 2431557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Significance of a Small Component of Choriocarcinoma in Testicular Mixed Germ Cell Tumor (MGCT).
    Hassan O; Epstein JI
    Am J Surg Pathol; 2018 Aug; 42(8):1113-1120. PubMed ID: 29794869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the clinical diagnostic value of β-hCG and αFP for intracranial germ cell tumors.
    Hu M; Guan H; Lau CC; Terashima K; Jin Z; Cui L; Wang Y; Li G; Yao Y; Guo Y; Li YM; Zhong D; Xiao J; Wan X; Lian X; Feng F; Ren H; Zhao Y; Cheng X; Gu F
    Eur J Med Res; 2016 Mar; 21():10. PubMed ID: 26968839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).
    Seidel C; Daugaard G; Tryakin A; Necchi A; Cohn-Cedermark G; Ståhl O; Hentrich M; Brito M; Albany C; Taza F; Gerl A; Oechsle K; Oing C; Bokemeyer C
    Urol Oncol; 2019 Nov; 37(11):809.e19-809.e25. PubMed ID: 31494007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of elevated level of hCG in serum on clinical course and radiotherapy results in the histology-confirmed intracranial germinomas.
    Shin KH; Kim IH; Choe G
    Acta Oncol; 2001; 40(1):98-101. PubMed ID: 11321670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic features of human chorionic gonadotropin- or alpha-fetoprotein-producing germ cell tumors of the central nervous system: histological heterogeneity and surgical meaning.
    Sugiyama K; Arita K; Tominaga A; Hanaya R; Taniguchi E; Okamura T; Itoh Y; Yamasaki F; Kurisu K
    Brain Tumor Pathol; 2001; 18(2):115-22. PubMed ID: 11908867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levels.
    Speir RW; Calaway AC; Einhorn LH; Foster RS; Cary C
    Urol Oncol; 2020 Aug; 38(8):687.e19-687.e23. PubMed ID: 32448503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy for primary intracranial germ-cell tumors.
    Wolden SL; Wara WM; Larson DA; Prados MD; Edwards MS; Sneed PK
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):943-9. PubMed ID: 7607968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of overall survival in primary intracranial pure choriocarcinoma.
    Jiang T; Raynald ; Yang H; Zhang W; Li C
    J Clin Neurosci; 2019 Mar; 61():93-101. PubMed ID: 30442453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.